LEXARIA BIOSCIENCE CORP.: 10-K filed 2014-01-24
What LEXARIA BIOSCIENCE CORP. reported in its annual report filed 2014-01-24 (fiscal FY 2013): 23 published measures, 48 facts as tagged in accession 0001062993-14-000329.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-01-24
- Fiscal period
- fiscal FY 2013
- Accession
- 0001062993-14-000329 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LEXARIA BIOSCIENCE CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 3,573,352 | USD | |
| At 2012-10-31 | 4,191,753 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 1,474,448 | USD | |
| At 2012-10-31 | 1,770,577 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 2,098,904 | USD | |
| At 2012-10-31 | 2,421,176 | USD | |
| At 2011-10-31 | 2,661,348 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 65,542 | USD | |
| At 2012-10-31 | 180,514 | USD | |
| At 2011-10-31 | 31,201 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 321,000 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 135,943 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -365,359 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 287,502 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -70,613 | USD | 365 |
| 2011-11-01 to 2012-10-31 | -274,132 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | -5,057,677 | USD | |
| At 2012-10-31 | -4,714,126 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 21,279 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 11,336 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 146,266 | USD | |
| At 2012-10-31 | 472,925 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 267,357 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 237,641 | USD | 366 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 1,415,203 | USD | |
| At 2012-10-31 | 1,711,332 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 79,217 | USD | |
| At 2012-10-31 | 290,936 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 645,802 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 826,002 | USD | 366 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 302,251 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 574,494 | USD | 366 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 795,204 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 783,268 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 16,431,452 | shares | |
| At 2012-10-31 | 16,431,452 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 7,140,150 | USD | |
| At 2012-10-31 | 7,118,871 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 1,507 | USD | |
| At 2012-10-31 | 1,475 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -343,551 | USD | 365 |
| 2011-11-01 to 2012-10-31 | -251,508 | USD | 366 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 6,755 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 2,966 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -211,719 | USD | 365 |
| 2011-11-01 to 2012-10-31 | 60,056 | USD | 366 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 69,230 | USD | 365 |
| 2011-11-01 to 2012-10-31 | -55,270 | USD | 366 |
Inspect the source
- Entity
- LEXARIA BIOSCIENCE CORP. / CIK 0001348362
- Captured
- 2026-09-20T07:55:03.045Z
- SEC response SHA-256
c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))